Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Molecular Sciences|August 7, 2021
Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host DiseasePeter Cuthbertson, Nicholas J Geraghty, Sam R Adhikary, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2022
Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host DiseaseDebbie Watson, Sam R Adhikary, Peter Cuthbertson, et al.
Molecular Therapy. Methods & Clinical Development|October 12, 2023
Adeno-associated virus serotype 9 antibody seroprevalence for patients in the United States with spinal muscular atrophyJohn W Day, Jerry R Mendell, Arthur H M Burghes, et al.
Immunology and Cell Biology|May 16, 2023
Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft-versus-host disease development in humanized mice treated with post-transplant cyclophosphamideChloe Sligar, Peter Cuthbertson, Nicole A Miles, et al.
Clinical Science (London, England : 1979)|January 15, 2020
Increased P2X7 expression in the gastrointestinal tract and skin in a humanised mouse model of graft-versus-host diseasePeter Cuthbertson, Sam R Adhikary, Nicholas J Geraghty, et al.
Sexually Transmitted Infections|February 20, 2010
Assessment of intervention outcome in the absence of baseline data: 'reconstruction' of condom use time trends using retrospective analysis of survey dataC M Lowndes, M Alary, S Verma, et al.
Immunology|May 22, 2021
Post-transplant cyclophosphamide limits reactive donor T cells and delays the development of graft-versus-host disease in a humanized mouse modelSam R Adhikary, Peter Cuthbertson, Leigh Nicholson, et al.
BMC Public Health|March 2, 2012
Assessment of the scale, coverage and outcomes of the Avahan HIV prevention program for female sex workers in Tamil Nadu, India: is there evidence of an effect?S Thilakavathi, K Boopathi, C P Girish Kumar, et al.
Clinical and Experimental Immunology|July 1, 2017
The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host diseaseN J Geraghty, L Belfiore, D Ly, et al.
Pageof 2